1. Market Research
  2. > Pharmaceutical
  3. > Prescription Drug Market Trends
Shire Company Analysis

Shire Company Analysis

  • August 2017
  • 45 pages
  • ID: 5182416
  • Format: PDF
  • By Datamonitor Healthcare


Table of Contents

Updated analysis and forecasts based on Q2 2017 company-reported sales.

Pharmavitae Analytics explores Shire’s prescription pharmaceutical performance and outlook, encompassing corporate strategy, marketed portfolio, pipeline potential, and financial performance over 2016–26.

Overview – Shire will generate $18bn in product sales by 2026, as recent acquisitions fuel inorganic growth and offset losses in the CNS portfolio.
2021 Outlook – Inorganic and organic growth in the rare diseases and CNS portfolios, respectively, will fuel a CAGR of 9.5% out to 2021.
2026 Outlook – Approximately $6.8bn will be added to Shire’s topline out to 2026, as the rare diseases portfolio continues to show impressive growth.
Pipeline – Shire’s pipeline will add $2.7bn out to 2026 as the company continues to expand its presence in rare diseases.
Events – Growth in the rare diseases and ophthalmology portfolios will drive growth and offset losses in the CNS portfolio from generic entries.

Shire’s M&A strategy has made it a global leader in rare diseases and highly specialized conditions.
Shire’s CNS portfolio will decline at a CAGR of -6.2% over the forecast period, meaning that its contribution to the overall business will decrease.
Shire is tightening its grip on the HAE market following the acquisitions of ViroPharma and Dyax.
Xiidra will experience strong growth as Shire’s only currently marketed ophthalmology product.

Model updates
Inclusion of SHP616.
Launch of rival Haegarda.
Launch of Mydayis.

Analysis structure
Company context

How is Shire strategically poised out to 2026?
What are Shire’s key strengths, weaknesses, opportunities, and threats?
What are Shire’s key catalysts over the next four quarters?

Facts and figures
What is Shire’s forecasted sales performance out to 2026?
What is the revenue trajectory of Shire’s current top 10 products out to 2026?
Which therapy areas will experience the largest growth and decline?
What are the portfolio weightings of Shire based on the lifecycle of products?

Key therapy areas
Why will specific therapy areas experience the largest growth and decline?
What are the detailed competitive dynamics at play in Shire’s important therapeutic markets?
How is Shire adapting strategically to internal and external headwinds?

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.


Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on